The mechanisms by which hormones and growth factors stimulate the somatic growth of the fetus are poorly understood. Most of the classical hormones that stimulate postnatal growth appear to have little influence on the fetus. In this proposal, which is based on the supposition that peptide growth factors are important mediators of fetal growth, emphasis is placed on determining the role of the somatomedins in this process. We have extensive experience with fetal and postnatal studies of the growth hormone dependent mitogen, somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I). We propose to continue these studies and to incorporate parallel research on insulin-like growth factor II. Using animal models for intrauterine and neonatal growth retardation we will attempt to define the relationships among somatic growth, serus and tissue concentrations of the somatomedins, and growth hormone binding. Because there is growing evidence that the somatomedins act through autocrine and/or paracrine mechanisms, we propose to determine concentrations of the somatomedins in human fetuses and neonates, and to relate these measurements to serum concentrations and growth. We will carry out experiments designed to define the intracellular forms of the somatomedins in the fetus, and we will continue work directed at defining the chemical nature, physiological regulation and biologic actions of somatomedin binding proteins. Using cDNA probes for the somatomedins, we will carry out studies of cellular localization of expression of the Sm-C/IGF-I gene by in situ cDNA/mRNA hybridization, in parallel with immunocytochemical studies of somatomedin. We will then proceed to quantify concentrations of somatomedin mRNAs in fetal rat and human tissues. In this way we hope to determine the sites and ontogeny of fetal somatomedin syntheses. In addition, we plan to characterize somatomedin gene polymorphism in disorders causing intrauterine growth retardation. Finally, we will continue studies using our recently described ubiquitin precursor cDNA probe. These will be directed at determining changes in ubiquitin mRNA through development and defining factors that regulate expression of ubiquitin genes during development. Ubiquitin's unique role in protein degradation and possible role in transcription make it likely to be important during fetal growth and development.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD008299-17
Application #
3310847
Study Section
Endocrinology Study Section (END)
Project Start
1977-06-01
Project End
1991-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
17
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hu, Qichen; Lee, Seong Yong; O'Kusky, John R et al. (2012) Signalling through the type 1 insulin-like growth factor receptor (IGF1R) interacts with canonical Wnt signalling to promote neural proliferation in developing brain. ASN Neuro 4:
Liu, Wen; D'Ercole, Joseph A; Ye, Ping (2011) Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury. BMC Neurosci 12:64
Lehtinen, Maria K; Zappaterra, Mauro W; Chen, Xi et al. (2011) The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron 69:893-905
Ye, Ping; Hu, Qichen; Liu, Hedi et al. (2010) beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures. Glia 58:1031-41
Moy, S S; Nadler, J J; Young, N B et al. (2009) Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav 8:129-42
Liu, Wen; Ye, Ping; O'Kusky, John R et al. (2009) Type 1 insulin-like growth factor receptor signaling is essential for the development of the hippocampal formation and dentate gyrus. J Neurosci Res 87:2821-32
Joseph D'Ercole, A; Ye, Ping (2008) Expanding the mind: insulin-like growth factor I and brain development. Endocrinology 149:5958-62
Zhang, Jihui; Liu, Wen; Ye, Ping et al. (2007) Pitfalls of PCR-based strategy for genotyping cre-loxP mice. Biotechniques 42:281, 283
Simmons, J G; Ling, Y; Wilkins, H et al. (2007) Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth. Am J Physiol Gastrointest Liver Physiol 293:G995-1003
Hodge, Rebecca D; D'Ercole, A Joseph; O'Kusky, John R (2007) Insulin-like growth factor-I (IGF-I) inhibits neuronal apoptosis in the developing cerebral cortex in vivo. Int J Dev Neurosci 25:233-41

Showing the most recent 10 out of 104 publications